Companies Molecular Templates, Inc.
Molecular Templates (MTEM): executive pay, fiscal 2023
Free brief. Every figure links to the company’s own filing.
Molecular Templates, Inc. no longer files a proxy statement; its last pay data is FY2023.
CEO pay, last three years
- $1,547,340FY2022
- $857,769FY2023
CEO total pay was $857,769 in fiscal 2023, down from $1,547,340 in fiscal 2022.
FY2023: salary $621,000 · bonus $92,219 · stock awards $0 · option awards $133,960
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Eric Poma | $621,000 | $92,219 | $0 | $133,960 | $0 | $0 | $10,590 | $857,769 |
| Chief Executive Officer and Chief Scientific Officer | ||||||||
| Jason Kim | 458,712 | 55,734 | 0 | 56,933 | 0 | 0 | 7,856 | 579,235 |
| President and Chief Financial Officer, and Treasurer | ||||||||
| Roger Waltzman | 282,472 | 0 | 0 | 56,933 | 0 | 0 | 6,164 | 345,569 |
| Former Chief Medical Officer | ||||||||
| Maurizio Voi | 112,032 | 11,329 | 0 | 44,544 | 0 | 0 | 635 | 168,540 |
| Former Chief Medical Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2023 total | FY2022 total | FY2021 total | Δ FY2022→2023 |
|---|---|---|---|---|
| Eric Poma | $857,769 | $1,547,340 | — | ↓ −689,571 |
| Jason Kim | 579,235 | 899,846 | — | ↓ −320,611 |
| Roger Waltzman | 345,569 | 899,720 | — | ↓ −554,151 |
| Maurizio Voi | 168,540 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Company's compensation program is designed to attract and retain qualified executives by providing a competitive base salary and an annual cash incentive bonus awarded at the discretion of the Board, along with long-term equity incentives in the form of stock options to align executive interests with stockholders.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Haigh & Company |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | false |
Equity grants and outstanding awards
No plan-based awards are on file for this fiscal year.
Outstanding equity awards at fiscal year-end 2023
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Jason Kim | Option | 418 | 217.5 | — |
| Eric Poma | Option | 870 | 217.5 | — |
| Jason Kim | Option | 2,431 | 210.75 | — |
| Jason Kim | Option | 4,519 | 41.55 | — |
| Eric Poma | Option | 5,838 | 210.75 | — |
| Eric Poma | Option | 10,840 | 41.55 | — |
| Maurizio Voi | Option | 11,333 | 5.5 | — |
| Jason Kim | Option | 11,333 | 7.2 | — |
| Eric Poma | Option | 26,666 | 7.2 | — |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Gabriela Gruia, M.DEmployee director | $115,327 | — | $75,216 | — | — | $190,542 |
| Harold E. “Barry” Selick, Ph.DIndependent · Board Chair · Audit · Compensation · Nominating and Corporate Governance (Chair) | 83,000 | — | 4,285 | — | — | 87,285 |
| David R. HoffmannIndependent · Audit (Chair) | 55,000 | — | 4,285 | — | — | 59,285 |
| Kevin LalandeIndependent · Audit · Compensation (Chair) | 50,000 | — | 4,285 | — | — | 54,285 |
| Jonathan LanfearIndependent · Departed during FY | 47,500 | — | 4,285 | — | — | 51,785 |
| Corsee Sanders, Ph.DIndependent · Compensation · Nominating and Corporate Governance | 45,000 | — | 4,285 | — | — | 49,285 |
| David Hirsch, M.D., Ph.DIndependent · Departed during FY | 6,438 | — | 0 | — | — | 6,438 |
| Scott MorensteinIndependent · Departed during FY | 0 | — | 0 | — | — | — |
Board fee structure and ownership guideline
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 15,000 / 10,000 / 8,000 |
| Stock ownership guideline | — |
Total cost of the board
| Component | FY2023 |
|---|---|
| Cash retainers and fees | $402,265 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $402,265 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Molecular Templates as a peer
Companies that benchmark against MTEM
No companies currently name MTEM as a compensation peer in their most recent disclosure.
This is the complete answer, not a partial one — the list is never padded.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Molecular Templates, Inc. | 2023 | Eric Poma | $621,000 | $0 | $133,960 | $0 | $857,769 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
No say-on-pay vote is on file for this company.
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (15 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Eric Poma. DEF 14A, filed 2024-08-13. Section “Summary Compensation Table” · page 22. As printed: 857,769. View filing ↗
- Section 01, Jason Kim. DEF 14A, filed 2024-08-13. Section “Summary Compensation Table” · page 22. As printed: 579,235. View filing ↗
- Section 01, Roger Waltzman. DEF 14A, filed 2024-08-13. Section “Summary Compensation Table” · page 22. As printed: 345,569. View filing ↗
- Section 01, Maurizio Voi. DEF 14A, filed 2024-08-13. Section “Summary Compensation Table” · page 22. As printed: 168,540. View filing ↗
- Section 08, Gabriela Gruia, M.D. DEF 14A, filed 2024-08-13. Section “Director Compensation”. As printed: 190,542. View filing ↗
- Section 08, Harold E. “Barry” Selick, Ph.D. DEF 14A, filed 2024-08-13. Section “Director Compensation”. As printed: 87,285. View filing ↗
- Section 08, David R. Hoffmann. DEF 14A, filed 2024-08-13. Section “Director Compensation”. As printed: 59,285. View filing ↗
- Section 08, Kevin Lalande. DEF 14A, filed 2024-08-13. Section “Director Compensation”. As printed: 54,285. View filing ↗
- Section 08, Jonathan Lanfear. DEF 14A, filed 2024-08-13. Section “Director Compensation”. As printed: 51,785. View filing ↗
- Section 08, Corsee Sanders, Ph.D. DEF 14A, filed 2024-08-13. Section “Director Compensation”. As printed: 49,285. View filing ↗
- Section 08, David Hirsch, M.D., Ph.D. DEF 14A, filed 2024-08-13. Section “Director Compensation”. As printed: 6,438. View filing ↗
- Section 08, Scott Morenstein. DEF 14A, filed 2024-08-13. Section “Director Compensation”. As printed: —. View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 09b board cost (computed). Computed. Cash 402,265 + equity 0 + all other 0 = 402,265, summed across the director compensation table rows.
- Molecular Templates, Inc. (subject), Section 10b CEO total. DEF 14A, filed 2024-08-13. CEO total compensation as printed in Molecular Templates, Inc.'s own proxy. As printed: 857,769. View filing ↗